FDA approves Recarbrio for cUTI, cIAI treatment in adults
July 17, 2019
Recarbrio is a three-drug combined injection of imipenem/cilastatin and relebactam.
FDA issues warning on insulin pump cybersecurity weakness
June 28, 2019
The MiniMed 508 and MiniMed Paradigm series insulin pumps are being recalled because of potential cybersecurity risks; 4,000 patients in the United States are affected.
FDA approves new treatment for hospital-acquired, ventilator-associated bacterial pneumonia
June 4, 2019
The new indication is based on results of a multinational, double-blind study involving a different antibacterial drug.
Only 1.5% of individuals at high risk of opioid overdose receive naloxone
May 3, 2019
“Clinicians can address this gap by regularly prescribing naloxone to eligible patients.”
FDA approves generic naloxone spray for opioid overdose treatment
April 19, 2019
The agency said the naloxone nasal spray does not need assembly and can be used by anyone, regardless of medical training.
Proportion of women speaking at medical conferences rises over decade
April 12, 2019
Though the proportion of female speakers at medical conferences has increased during the last decade, women continue to be underrepresented.
FDA to expand opioid labeling with instructions on proper tapering
April 10, 2019
The label changes are intended to be used when both the clinician and patient have agreed to reduce the opioid dosage.
Artesunate to become first-line malaria treatment in U.S.
March 28, 2019
Artesunate will become the first-line treatment for malaria in the United States, following the discontinuation of quinidine.
NIH announces new clinical trial assessing FMT for recurrent CDAD
January 15, 2019
The trial will test the safety and efficacy of a standardized protocol with follow-up.
Guideline-concordant treatment still unlikely in nonchildren’s hospitals for pediatric CAP
December 19, 2018
This is concerning because the majority of children hospitalized with pneumonia are treated in nonchildren’s hospitals.